Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca's Datroway Approved to Treat Non-Small Cell Lung Cancer in U.S.
02:32am, Tuesday, 24'th Jun 2025
The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a Phase 2 trial. The approval was also supported by data from a Phase 3 trial
US approves AstraZeneca, Daiichi's treatment for lung cancer
02:15am, Tuesday, 24'th Jun 2025
AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung cancer, adding that the drugmaker would now pay partner Daiichi Sankyo $45 million in
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
10:46am, Monday, 23'rd Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 20'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AstraZeneca and GSK fall after Trump renews pharma tariff threat
09:48am, Wednesday, 18'th Jun 2025
Shares in AstraZeneca PLC (LSE:AZN), the largest company on the FTSE 100 index, and fellow blue chip GSK PLC (LSE:GSK, NYSE:GSK) were down 1.4% and 1.9% respectively on renewed worries about US dru
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
07:16pm, Monday, 16'th Jun 2025
Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.
Is Trump targeting the NHS in trade negotiations? This reports says it is
10:03am, Monday, 16'th Jun 2025
Britain could face higher drug costs as part of a deal to stave off future tariffs from Donald Trump, according to a report in the Daily Telegraph. Documents released after a recent trade agreement sh
5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List
03:26am, Saturday, 14'th Jun 2025
I highlight 15 dividend-paying stocks from Bloomberg's 50 Companies to Watch that meet my 'safer' criteria: free cash flow yields exceed dividend yields. The top ten dividend focus stocks offer an est
AstraZeneca bets big on AI and China with $3.6bn CSPC collaboration
06:01am, Friday, 13'th Jun 2025
AstraZeneca PLC (LSE:AZN) is betting big on AI-enabled drug discovery (and China), agreeing a research collaboration with China's CSPC Pharmaceutical Group that could see the Anglo-Swedish drugmaker
AstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 Billion
05:29am, Friday, 13'th Jun 2025
The deal with China's CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.
AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC
04:40am, Friday, 13'th Jun 2025
AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.
Leading bank sees AstraZeneca upside seen in hypertension drug, tempers lung cancer hopes
11:02am, Thursday, 12'th Jun 2025
UBS has reiterated its 'buy' rating on AstraZeneca PLC (LSE:AZN) with a 12-month price target of 14,200p, offering potential upside of just over 30% from the current share price of 10,907p. The focus
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
10:51am, Friday, 06'th Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AstraZeneca CEO: We totally agree with President Trump on this
05:30pm, Wednesday, 04'th Jun 2025
AstraZeneca CEO Pascal Soriot unpacks President Donald Trump's drug cost cut executive order on 'The Claman Countdown.' #foxbusiness #health #trump #maha
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
03:34pm, Tuesday, 03'rd Jun 2025
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.
